Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016
Summary
Global Markets Directs, Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Recurrent Glioblastoma Multiforme (GBM), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Recurrent Glioblastoma Multiforme (GBM) and features dormant and discontinued projects.
Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=719501
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Click to submit Query/ Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=719501
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Recurrent Glioblastoma Multiforme (GBM) Overview 9
Therapeutics Development 10
Pipeline Products for Recurrent Glioblastoma Multiforme (GBM) Overview 10
Pipeline Products for Recurrent Glioblastoma Multiforme (GBM) Comparative Analysis 11
Recurrent Glioblastoma Multiforme (GBM) Therapeutics under Development by Companies 12
Recurrent Glioblastoma Multiforme (GBM) Therapeutics under Investigation by Universities/Institutes 15
Recurrent Glioblastoma Multiforme (GBM) Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
Recurrent Glioblastoma Multiforme (GBM) Products under Development by Companies 19
Recurrent Glioblastoma Multiforme (GBM) Products under Investigation by Universities/Institutes 23
Recurrent Glioblastoma Multiforme (GBM) Companies Involved in Therapeutics Development 24
AbbVie Inc. 24
About ResearchMoz
ResearchMoz is the worlds fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMozs service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Latest Press-Releases: http://www.researchmoz.us/pressrelease